HTGF et al. close finance round for Protectimmun

The funding will be used to carry out the pre-clinical testing and preparation of clinical studies. The company will also leverage from the investor network in order to further develop the business.

The start of the first clinical study is expected in 2013.

Company
Founded in 2007, Protectimmun GmbH is based in Gelsenkirchen and is a researcher and developer of drugs in the field of allergic and chronic inflammatory diseases. The firm is creating a medical product which offers long-tem protection against the development of allergic airway diseases to children.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Early-stage
• Healthcare
• Now researching
• Germany
• High-Tech Gründerfonds